CBIO vs QTTB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CBIO

59.3
AI Score
VS
CBIO Wins

QTTB

52.6
AI Score

Investment Advisor Scores

CBIO

59score
Recommendation
HOLD

QTTB

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBIO QTTB Winner
Revenue 1.04M 8.01M QTTB
Net Income -48.12M -26.68M QTTB
Net Margin -4631.4% -333.0% QTTB
Operating Income -51.09M -22.45M QTTB
ROE -29.5% 17.1% QTTB
ROA -26.3% -19.0% QTTB
Total Assets 182.76M 140.06M CBIO
Cash 171.59M 36.26M CBIO
Current Ratio 9.66 4.22 CBIO
Free Cash Flow -28.56M -7.97M QTTB

Relative Price Performance (Last 90 Days)

CBIO 1M: -7.8% · 3M: -19.7% QTTB 1M: -7.1% · 3M: -41.4%

Current Technical Phase

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.5%), weak momentum, RSI 41

RSI (14): 40.7 · Price: $13.08

QTTB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.1 · Price: $8.88

Fundamentals Snapshot

Metric CBIO QTTB
Market Cap — —
Forward P/E -5.0 -3.8
Trailing P/E — 2.5
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 1.0% 0.7%
Operating Margin -14.3% 0.4%
EPS -7.63 3.49
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.